Danske Bank’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Danske Bank’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-100	Closed	-$3.33K	–	1701
2024 Q3	$3.33K	Sell	100 -600	-86%	-$20.7K	﹤0.01%	1450
2024 Q2	$18.9K	Buy	+700	New	+$13.8K	﹤0.01%	1064

Danske Bank's LBPH Position: Q4 2024 in Review

Danske Bank sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 100 shares — an estimated $3.33K sold.

Danske Bank first reported a position in LBPH in Q2 2024 and held it in 2 quarters. The position peaked at $18.9K in Q2 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Danske Bank reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Danske Bank sold 100 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $3.33K.
Danske Bank first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
Danske Bank's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $18.9K in Q2 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Danske Bank's 13F filing for Q4 2024, filed 18 Mar 2026.